Drug General Information (ID: DDI4F01WYN)
  Drug Name Folic acid Drug Info Methsuximide Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Vitamins Anticonvulsants
  Structure

 Mechanism of Folic acid-Methsuximide Interaction (Severity Level: Moderate)
     Increased metabolism (Unspecific) Click to Show/Hide Mechanism Graph
      Drug Name Folic acid Methsuximide
      Mechanism 1 Folic acid Increase the metabolism of circulating folate
      Key Mechanism Factor 1
Factor Name Pharmacokinetics
Factor Description Alters the metabolism of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects.
      Mechanism Description
  • Increased metabolism of Folic acid caused by Methsuximide 
     Antagonize the effect of antiepileptic agents Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Folic acid Methsuximide
      Mechanism 2 Reduce the anticonvulsant effect of antiepileptic agent Antiepileptic agent
      Key Mechanism Factor 2
Factor Name Antiepileptic agents
Factor Description The beneficial effects of antiepileptic drugs may be reduced, leading to an increase in seizure frequency or duration.
      Mechanism Description
  • Antagonize the effect of Methsuximide when combined with Folic acid 

Recommended Action
      Management Caution is advised when folate therapy is coadministered with anticonvulsants. Close monitoring for clinical and laboratory evidence of diminished therapeutic response to both treatments is recommended. Patients should be advised to notify their physician if they experience loss of seizure control.

References
1 Berg MJ, Fischer LJ, Rivey MP, Vern BA, Lantz RK, Schottelius DD "Phenytoin and folic acid interaction: a preliminary report." Ther Drug Monit 5 (1983): 389-94. [PMID: 6659012]
2 Katz M "Potential danger of self-medication with folic acid." N Engl J Med 289 (1973): 1095. [PMID: 4742232]
3 Furlanut M, Benetello P, Avogaro A, Dainese R "Effects of folic acid on phenytoin kinetics in healthy subjects." Clin Pharmacol Ther 24 (1978): 294-7. [PMID: 688723]